ApplicationNo. 380379 filed on 09/01/1999
US Classes:514/266.2, Additional hetero ring attached directly or indirectly to the quinazoline ring system by nonionic bonding514/255.05, Additional hetero ring attached directly or indirectly to the 1,4-diazine ring by nonionic bonding514/266.21, The additional hetero ring is six-membered consisting of one nitrogen and five carbons514/266.22, Piperidinyl or tetrahydropyridyl514/406, Pyrazoles514/473Chalcogen bonded directly to the hetero ring
ExaminersPrimary: Jarvis, William R. A.
Attorney, Agent or Firm
Foreign Patent References
International ClassesA61K 031/505
Foreign Application Priority Data1998-06-29 SE
AbstractThe invention relates to the co-administration of an inhibitor of induced nitric oxide synthase and an inhibitor of cyclooxygenase-2 for the treatment of inflammation and inflammatory disorders.